BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
수요일, 9월 30

Praxis Precision Medicines Inc

PRAXNASDAQ
Trade with Public
Trade with Public
$281.00
-4.65-1.63%
가까이에: Sep 29, 5:00 PM EST
$281.08
0.08430.03%
시간외: 4:15 PM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교옵션주식 보고서

Praxis Precision Medicine Analyst Price Targets

Wall Street analyst price targets and consensus rating for Praxis Precision Medicine (PRAX).

Price Target Range — 10 Quarters

Analyst Consensus — 17 Analysts

16Buy
1Sell
Consensus RatingBuy# Analysts17Avg. Consensus PT$539Upside to Avg. PT+91.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →
DateFirmAnalystActionRating ChangePrice Target
Sep 24, 2026HC Wainwright & Co.Douglas TsaoMaintainedBuy$1201
Sep 24, 2026NeedhamAmi FadiaMaintainedBuy$582
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Praxis Precision Medicine, Maintains $1201 Price Target

HC Wainwright & Co. analyst Douglas Tsao reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $1201 price target.
Benzinga Newsdesk

PRO
Needham Reiterates Buy on Praxis Precision Medicine, Maintains $582 Price Target

Needham analyst Ami Fadia reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $582 price target.
Benzinga Newsdesk

PRO
Goldman Sachs Maintains Buy on Praxis Precision Medicine, Raises Price Target to $575

Goldman Sachs analyst Kevin Strang maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $470 to $575.
Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Praxis Precision Medicine, Raises Price Target to $462

RBC Capital analyst Leonid Timashev maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Outperform and raises the price target from $449 to $462.
Benzinga Newsdesk

PRO
Wells Fargo Maintains Equal-Weight on Praxis Precision Medicine, Raises Price Target to $362

Wells Fargo analyst Benjamin Burnett maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Equal-Weight and raises the price target from $323 to $362.
Benzinga Newsdesk

PRO
Needham Maintains Buy on Praxis Precision Medicine, Raises Price Target to $582

Needham analyst Ami Fadia maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $575 to $582.
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

시장 데이터 제공 Benzinga API

BenzingaBenzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved